6.250USD+1.46%Mkt Cap: 259.96M $P/E: —2d ago
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It …
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap259.96M $
Enterprise Value55.08M $
Revenue (TTM)127.58M $
Gross Profit103.01M $
Net Income (TTM)-38.94M $
Revenue/Share3.094 USD
Last Price6.250 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees461
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.74
PEG—
EV/EBITDA-1.07
EV/Revenue0.43
P/S1.99
P/B0.94
EPS (TTM)-1.13
EPS (Forward)-0.70
52W Range
4.48020% of range13.22
52W High13.22 USD
52W Low4.480 USD
Profitability
Gross Margin76.60%
Oper. Margin-40.81%
EBITDA Margin-40.42%
Profit Margin-28.96%
ROE-14.13%
ROA-12.49%
Growth
Revenue Growth0.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.51M $
CapEx (TTM)3.83M $
FCF Margin-5.28%
FCF Yield-2.59%
Net Debt-198.22M $
Net Debt/EBITDA3.84
Balance Sheet
Debt/Equity0.04
Current Ratio4.07
Quick Ratio3.57
Book Value/Sh6.459 USD
Cash/Share5.020 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating3.1 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)7.787 USD
Upside (mean)+24.6%
Target Range6.000 USD – 11.00 USD
$6.000+24.6% to mean$11.00
# Analysts8
Ownership
Shares Out.41.59M
Float36.26M
Insiders6.42%
Institutions100.53%
Short Interest
Short Ratio3.3d
Short % Float10.29%
Short % Out.9.75%
Shares Short4.06M
Short (prev mo.)5.51M
Technical
SMA 505.602 (+11.6%)
SMA 2007.706 (-18.9%)
Beta1.13
S&P 52W Chg18.16%
Avg Vol (30d)922.85K
Avg Vol (10d)808.43K
Technical Indicators
RSI (14)50.5
MACD0.3160
MACD Signal0.3250
MACD Hist.-0.0090
BB Upper7.296 USD
BB Middle6.212 USD
BB Lower5.128 USD
BB Width34.91%
ATR (14)0.4069 USD
Vol Ratio (20d)0.70x